An open-label, multicentre safety study of vemurafenib in patients with BRAF V600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system
Titel:
An open-label, multicentre safety study of vemurafenib in patients with BRAF V600-mutant metastatic melanoma: final analysis and a validated prognostic scoring system
Auteur:
Larkin, James Brown, Michael P. Arance, Ana M. Hauschild, Axel Queirolo, Paola Vecchio, Michele Del Ascierto, Paolo A. Krajsová, Ivana Schachter, Jacob Neyns, Bart Garbe, Claus Sileni, Vanna Chiarion Mandalà, Mario Gogas, Helen Espinosa, Enrique Hospers, Geke Lorigan, Paul Nyakas, Marta Guminski, Alex Liszkay, Gabriela Rutkowski, Piotr Miller Jr., Wilson Donica, Margarita Makrutzki, Martina Blank, Christian